Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Clinical Colorectal Cancer, 2(21), p. 141-148, 2022

DOI: 10.1016/j.clcc.2022.01.005

Links

Tools

Export citation

Search in Google Scholar

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Journal article published in 2022 by Davide Ciardiello ORCID, Vincenzo Famiglietti, Stefania Napolitano ORCID, Lucia Esposito, Filippo Pietrantonio, Antonio Avallone, Evaristo Maiello ORCID, Chiara Cremolini ORCID, Teresa Troiani, Erika Martinelli, Fortunato Ciardiello, Giulia Martini ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO